Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

• Last SEC data release: 2024-10-11
• Last 15 days FTD volume: NZ$1.51 M
• Last 3 months FTD volume: NZ$2.85 M
• Last year FTD volume: NZ$2.85 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Ultragenyx RARE	NZ$0.7 M	NZ$7.28 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	NZ$5.84 M	NZ$16.36 M	🇺🇸 USA
Pfizer PFE	NZ$0.18 B	NZ$0.53 B	🇺🇸 USA
Regeneron Pharmaceuticals REGN	NZ$12.86 M	NZ$0.10 B	🇺🇸 USA
Amicus Therapeutics FOLD	NZ$0.13 M	NZ$6.18 M	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	NZ$2.6 M	NZ$21.9 M	🇺🇸 USA